---
area: society-systems
category: science
companies_orgs:
- University of Toronto
- Sick Kids Hospital
- Food Allergy Canada
- McMaster University
- Health Canada
- UniQure
date: '2025-12-03'
draft: true
guest: ''
insight: ''
layout: post.njk
media_books:
- Pediatrics
people:
- Robert F. Kennedy Jr.
products_models:
- AMT130
- CRISPR
- LEAP trial
project: []
series: ''
source: https://www.youtube.com/watch?v=yOW6NsCV2j8
speaker: TVO Today
status: evergreen
summary: 本文深入探讨了医学研究的两大前沿领域：罕见病治疗和食物过敏预防。在罕见病方面，我们了解了亨廷顿病基因疗法和SPG50单患者基因疗法的突破性进展，以及患者社群和家庭在推动治疗中的关键作用。文章强调了基因筛查和政府投资的重要性。在食物过敏方面，重点介绍了早期引入花生可显著降低过敏风险的最新研究，并讨论了对抗医疗错误信息和未来研究方向。
tags:
- health
- medical-research
- misinformation
- peanut-allergy
- public-health
title: 罕见病突破与过敏症缓解：基因疗法和花生过敏预防的最新进展
---

### 罕见病治疗的希望曙光

医学界有句俗语：“听到蹄声，要想到马，而不是斑马。”这意味着在诊断时，应首先考虑常见病因。当然，那些蹄声也可能来自斑马，即使这种可能性很小。这正是斑马成为**罕见病**（Rare Diseases: 影响少数人群但全球总数庞大的疾病）象征的原因。有些罕见病确实非常罕见，只影响少数人，但总人数却相当可观。据估计，全球有超过4亿人患有罕见病。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">There's a saying in medicine, when you hear hoof beatats, think horses, not zebras. Meaning, when you're diagnosing, think of common causes first. But of course, those hoof beatats could be a zebra, even if it's unlikely. That's why the zebra is the symbol for rare diseases. And some are very rare indeed, affecting only a few people. But the overall number is considerable. It's estimated that more than 400 million people around the world have a rare disease.</p>
</details>

历史上，为罕见病寻找资金和治疗方法一直很困难，但新的基于DNA的**基因疗法**（Gene Therapy: 基于DNA技术，通过修改基因来治疗疾病的方法）正带来希望。它们会是改变游戏规则的关键吗？此外，十年前，一项具有里程碑意义的研究彻底颠覆了我们对预防花生过敏的认知。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">Historically, finding funding and treatments has been tough, but new DNA based gene therapies are offering hope. Could they be a gamecher? Then 10 years ago, a landmark study totally upended what we thought we knew about preventing peanut allergies.</p>
</details>

这项研究迫使当时的指导方针进行了彻底的逆转。十年后，我们现在正看到其带来的成果。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">It forced a complete reversal of guidelines at the time. And a decade later, we are now seeing the results.</p>
</details>

基于DNA的基因疗法有潜力彻底改变我们对罕见病的理解，并提供新的治疗方法。为了了解更多，我采访了多伦多大学研究员瑞秋·哈丁（Rachel Harding），她介绍了**亨廷顿病**（Huntington's Disease: 一种罕见的遗传性神经退行性疾病，表现为运动、思维和精神症状逐渐恶化）的医学突破。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">DNA based gene therapies have the potential to revolutionize our understandings of rare diseases and offer new treatments. To learn more, I talked to University of Toronto researcher Rachel Harding about medical breakthroughs in Huntington's disease.</p>
</details>

随后，我与特里·普瓦拉基斯（Terry Purvalakis）进行了交谈，他讲述了他年幼的儿子迈克尔（Michael）的故事，迈克尔是全球约80名患有**SPG50**（Paraplegia Type 50: 一种罕见的遗传性疾病，导致进行性瘫痪和其他神经系统症状）儿童中的一员。特里分享了迈克尔的生活如何因多伦多**病童医院**（Sick Kids Hospital: 一家著名的儿童医院，在此进行了单患者基因疗法试验）进行的首次单患者基因疗法试验而改变的故事。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">Then I spoke with Terry Purvalakis about his young son, Michael, one of an estimated 80 children around the world with a condition known as parapolgia type 50. Terry shares the story of how Michael's life was changed thanks to the first single patient gene therapy trial at Sick Kids Hospital in Toronto.</p>
</details>

### 亨廷顿病基因疗法：75%减缓进展

Rachel: 特里，欢迎来到《Rundown》。你们好吗？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Rachel Terry, welcome to the rundown. How are you doing?</p>
</details>

Terry: 很好。谢谢邀请。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Great. Thank you for having us.</p>
</details>

主持人: 是的，谢谢你们的到来。这太棒了。没关系。瑞秋，我们从你开始吧。请给我们介绍一下最近的亨廷顿病基因疗法。具体来说，疾病进展减缓75%到底意味着什么？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah, thank you for having us. This is awesome. Yeah, no worries. Rachel, let's start with you. Walk us through the recent Huntington's disease gene therapy. Specifically, what does 75% slower disease progression actually mean?</p>
</details>

Rachel: 好的。那么，也许我们先从亨廷顿病是什么开始说起。这是一种罕见的遗传性**神经退行性疾病**（Neurodegenerative Disease: 导致神经细胞逐渐受损或死亡的疾病），其特征是进行性的运动（即行动）、思维和精神症状，这些症状会随着时间推移而不断恶化。所有患有亨廷顿病的人都会产生一种略有不同的亨廷顿蛋白。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah. So, maybe let's start with what Huntington's disease is. So, this is a rare inherited neurodeenerative disease characterized by progressive, which means symptoms that get worse and worse over time, which are motor, so movement, thinking um and psychiatric symptoms as well. And everyone who has Huntington's disease makes a slightly different version of a protein called the Huntington protein.</p>
</details>

主持人: 好的。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Okay?</p>
</details>

Rachel: 所以，由**UniQure**（一家公司，设计了亨廷顿病基因疗法）公司设计的基因疗法是通过脑部手术进行的。它将遗传指令封装在一种无害的病毒中，这种病毒会扩散到大脑中，并指示大脑减少产生这种有害形式的亨廷顿蛋白。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> And so the gene therapy that was designed by this company Uniure is delivered by brain surgery. Um and it's uh genetic instructions that are packaged into this harmless virus um that spreads through the brain and tells the brain to make less of this kind of harmful form of the Huntington protein.</p>
</details>

现在，已经有一大批人参与这项临床试验相当长一段时间了，我们几个月前刚刚获得了一些数据，这些数据似乎表明症状进展减缓了约75%。这意味着通常一年内会恶化的症状，现在需要四年才能达到同样的程度。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">And so there's been a whole bunch of folks who've been in this clinical trial for quite a long time now and we just got some data a few months ago now um which seems to suggest that there was slowing of symptom progression by about 75%. And so this is equated to symptoms that would normally progress um in their aggressiveness in the course of a year that would now take four years.</p>
</details>

主持人: 好的。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Okay.</p>
</details>

Rachel: 所以这真的很令人兴奋。这是第一家公司分享任何数据，表明他们能够减缓疾病的进程。不过，我们确实需要谨慎一点，因为这是一个非常小的试验。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So this is really exciting. This is the first time any company has shared a date any data that seems to suggest that they're able to slow down the course of the disease. We do have to be a little bit careful though because this is a very small trial.</p>
</details>

主持人: 请问有多少人？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So say how many people?</p>
</details>

Rachel: 12人。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> 12 people. Okay.</p>
</details>

Rachel: 之所以如此，是因为我们不想在完全确定其安全性和有效性之前，就对数百人进行脑部手术基因疗法。我们需要从最初的试验中获得良好的信号。所以我们只有12名受试者。这类试验的另一个问题是，进行安慰剂组试验并不总是实际或符合伦理的。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So which is because we don't want to give brain surgery gene therapies to hundreds of people at once until we're really sure you know are they safe? How well might they be working? We need to get some good signals from those first. Um and so we've just got 12 people. And the other problem with these kind of trials is it's not always practical or ethical to do um a placebo arm.</p>
</details>

所以他们实际上正在做的是观察他们所谓的**自然史队列**（Natural History Cohort: 一组患有特定疾病但未接受实验性治疗的患者，用于观察疾病的自然进展，作为临床试验的对照组）。他们跟踪患有亨廷顿病但未参与试验的人的数据，试图了解他们在没有药物的情况下会如何进展，然后进行比较。关于这种比较方法的有效性存在一些争议。但尽管如此，这仍然是令人鼓舞的一步。我总是喜欢想到那些超级勇敢的人，他们在不知道这种基因疗法是否绝对安全的情况下，接受了脑部手术。他们在过去几年里，大脑中一直有这种基因疗法，降低了这种有毒蛋白质的含量，这真是太棒了。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">So actually what they're doing is they're looking at what they call a natural history cohort. This is where they track data from people who have Huntington's disease u but they're not in the trial and we're trying to see how they would progress without the drug and then making that comparison. Um and so there's a bit of a debate about how good that is as a comparator. Um, but nonetheless, it's still an encouraging step forward. And I always like to think about these super brave people who took this gene therapy, had this brain surgery before they knew there was any possibility this might be definitely okay, and they've been walking around for the last few years with this gene therapy in their brain, lowering the amount of this toxic protein, and how amazing that is.</p>
</details>

### 患者社群的力量

主持人: 瑞秋，你认为促成我们现在看到的这些惊人成果的关键突破是什么？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Rachel, what would you say was the key breakthrough uh that allowed sort of these incredible results that we're seeing? Yeah, I would I always bring it back to the patient community.</p>
</details>

Rachel: 我总是把它归结为患者社群。亨廷顿病患者社群本身是最警惕、最有组织、对疾病相关的一切知识最了解的社群之一，他们知道如何组织起来，以及如何最好地参与临床试验。他们参与自然史研究，我认为有超过1万人每年都会去进行某些测量。如果这些人没有这样做，我们就无法进行这项试验并进行这种比较。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">The Huntington's community themselves are one of the most hypervigilant and organized communities most well read up on everything to do with their disease, how to organize and how to um best be involved with clinical trials. So their engagement with natural history studies all those I think it's over 10,000 people who signed up for every year they go and they get certain measurements made and if they these people hadn't done that we wouldn't have been able to do this trial and to make this comparison.</p>
</details>

我认为这是一件非常了不起的事情，这不仅仅是亨廷顿病患者，还包括他们的护理人员、伴侣，他们开车送患者去这些预约，以及他们的临床神经科医生。在我看来，这才是真正推动这个社群取得进展的关键。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">I think that's a really amazing thing and it's not just the folks who have Huntington's disease it's all their carers their partners who drive them to these appointments but their clinical neurologist um that is what has really enabled things for this community in my opinion</p>
</details>

### SPG50：一个家庭的抗争与突破

主持人: 特里，你对这种挣扎非常了解。你的儿子没有亨廷顿病，但你能给我们讲讲你儿子的经历吗？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Terry you know all about this type of struggle. Your son doesn't have Huntington's disease, but can you tell us a little about uh your son's journey?</p>
</details>

Terry: 是的，迈克尔患有SPG50，或者说是50型截瘫。我们被告知回家爱他吧。他将在10岁时腰部以下瘫痪，20岁时四肢瘫痪。他永远不能走路，也不能说话。那天晚上我们回家后都快疯了。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah, Michael had SP has SPG 50 or parapollegia type 50. We were told go home and love him. He'll be paralyzed from the waist down by the age of 10, quadripollegic by the age of 20. He'll never walk. He never talk. We went home and lost our minds that evening.</p>
</details>

我把自己锁在房间里。24小时后，我们意识到我们可以做些什么，基因疗法和**ASO**（Antisense Oligonucleotides: 反义寡核苷酸，一种通过靶向RNA来调节基因表达的治疗方法）是可以实现的疗法。一个半月后，我飞遍了世界各地。我见到了所有基因疗法专家。我们从德克萨斯州达拉斯聘请了一个团队，并开始为迈克尔进行这项疗法。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> I locked myself in a room. 24 hours later, we realized that we could do something that gene therapies and ASOs or antisotides. there was therapies that could be done. And uh a month and a half later, I flew around the world. I met all the experts in gene therapy. We hired a team out of Dallas, Texas, and we started doing this therapy for Michael.</p>
</details>

他们称之为“概念验证”。证明你可以创造一种疗法。大约一年后，我们证明它有效。它在小鼠和细胞中都有效。我们必须筹集450万美元。那时，我们多伦多的社群团结起来。我们在四年内筹集了450万美元。我们得以安全测试药物，制造疗法，并于2022年3月治疗了迈克尔。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">This uh they call it a proof of concept. Prove that you can create a therapy. Um about a year later, we showed that it would work. It was working in mice and it was working in cells. And we had to raise $4.5 million. At that point, um our community in Toronto came together. We raised $4.5 million over four years. and we were able to safety test the drug, make the therapy, and treat Michael in March of 2022.</p>
</details>

主持人: 我们有一些迈克尔的照片，我想让观众看看。迈克尔现在怎么样了？这张照片是什么时候拍的？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> We have some photos of Michael that I want our viewers to see. How is Michael doing today? When was this uh this photo taken?</p>
</details>

Terry: 这张照片是在他接受治疗之前很久拍的。他当时癫痫发作了大约3小时。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> This photo was taken uh well before his therapy. He had a major seizure that lasted about 3 hours.</p>
</details>

主持人: 哇。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Wow.</p>
</details>

Terry: 他们当时以为他活不下来了。这是他从那次严重的癫痫发作中醒来时的样子。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> And they didn't think he was going to survive. And this is him waking up from that crazy seizure.</p>
</details>

主持人: 我们这里也有一些照片。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> And we have some photos here as well.</p>
</details>

Terry: 是的，那是迈克尔12个月大的时候，他们诊断出他患有这种疾病。他们当时不完全知道是什么，但诊断他患有小头症。我们去了希腊朝圣，试图祈祷疾病消失。是的，这只是……

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah, that was uh when Michael was um 12 months of age when they diagnosed him with this disorder. Uh well they they didn't exactly know what it was but they diagnosed him with microphille. We went to Greece for a pilgrimage um to try to pray away the disease and um yeah and this was just</p>
</details>

主持人: 这是他。他是个快乐的小孩。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> this is him. He's a happy little kid. You know</p>
</details>

主持人: 他今天怎么样？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> how is he today? Is this</p>
</details>

Terry: 是的，他很好。迈克尔是这种疾病中最严重的儿童。但他能够与我们交流，告诉我们他想要什么。他会拥抱和亲吻我们。他会表达感情。他能够站立，你知道，他正在改善。但他曾是最严重的。这种疾病有一个谱系。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah, he's good. You know he's um Michael was the most severe child in the in the in the disorder. Um but he's able to communicate with us, tell us what he wants. Um he hugs and kisses us. He shows affection. um he's able to stand, you know, he's improving. Uh but he was the most severe. There's a spectrum of disorder. Right.</p>
</details>

主持人: 是的。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Right.</p>
</details>

Terry: 所以他可能永远不会走路。我们希望他有一天能说话，但如果他能告诉我们他很痛苦，或者他想换尿布，或者他想睡觉，那么当我们离开这个世界时，我们就会觉得圆满了。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> And um so he he probably will never walk. Um we hope that he'll talk someday, but if he's able to tell us that he's in pain or he wants his diaper changed or if he wants to go to bed, then when we're gone from this earth, we'll have we'll have a one.</p>
</details>

主持人: 是的。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah.</p>
</details>

### 罕见病治疗的挑战与未来方向

主持人: 瑞秋，这些结果告诉我们当前疾病防治医学研究的状况如何？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Rachel, what do these results tell us about the current state of disease fighting medical research? I think we're in a really exciting phase of drug discovery and finding um treatments for diseases which have often been overlooked because they're not seen as commercially viable by really large pharmaceutical companies.</p>
</details>

Rachel: 我认为我们正处于药物发现和寻找疾病治疗方法的非常激动人心的阶段，这些疾病常常被忽视，因为大型制药公司认为它们不具备商业可行性。现在我们拥有了几乎可以为不同类型的疾病进行“复制粘贴”的技术，并有望为许多人创造治疗方法。这在我们的社会中是一个非常令人兴奋的境地。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">Now we have technologies that allow us to almost copy paste for different types of disease and to create therapeutics hopefully for many many people. That's such an exciting place to be in our society.</p>
</details>

主持人: 现在基因编辑工具备受关注。我们听说过像**CRISPR**（Clustered Regularly Interspaced Short Palindromic Repeats: 基因编辑技术，允许科学家精确修改DNA序列）这样的技术，但亨廷顿病的治疗并未涉及它。请给我们介绍一下这项技术。你刚才提到了，但请再详细说明一下。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Um now there's a lot of excitement in gene editing tools. We've heard uh technologies like crisper, CRI, SPR, but in terms of this Huntington's treatment, it did not involve that. Uh tell us a little bit about the technology. You touched on a little bit, but tell us a little bit about the technology.</p>
</details>

Rachel: 是的，这项疗法像许多其他基因疗法一样，通过这种无害的病毒进行递送。这种药物本身叫做**AMT130**（一种基因疗法药物，用于亨廷顿病治疗）。病毒将一种叫做**微RNA**（microRNA: 一种小的非编码RNA分子，可以调控基因表达，在此疗法中用于抑制有害蛋白质的产生）的指令封装起来。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah, so um this therapy is delivered like many other uh gene therapies through this harmless virus. Um the drug itself is called AMT130. The virus packages the instructions for something called a microRNA.</p>
</details>

它附着在亨廷顿信使分子上。这有点像我们DNA遗传指令和它们编码的蛋白质之间的中间环节。我们有这些信使分子，它们是两者之间的桥梁，这样我们就可以忠实地复制DNA并将其转化为蛋白质。所以这种微RNA附着在那个信使上，然后阻止蛋白质的产生。这就是这项技术。你可以想象，现在我们知道如何为不同的疾病做到这一点，我们可能会发现另一种疾病，我们想关闭另一个基因或降低另一种蛋白质的水平。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">This sticks onto the Huntington message molecule. This is kind of the in between of our DNA genetic instructions and the proteins that they encode. And we have these message molecules that kind of are the in between of those so that we can faithfully copy the DNA and turn it into protein. Um, and so this microRNA sticks on to that message and then stops the protein being made. Um, and so that's the technology. And so you can imagine that, you know, now we know how to do this for different diseases. we might find another disease where we want to switch off another gene or turn down the levels of another protein.</p>
</details>

主持人: 特里，即使科学对这类疾病充满希望，显然也存在一些真正的障碍。你提到了一个数字，400万。这只是谈话的一方面，但请告诉我们，家庭在面对这些诊断时面临着哪些障碍。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Terry, even when the science is promising for diseases like this, there are obviously some real barriers. You tal you mentioned a number there, four four million. Uh that's just one side of the [clears throat] conversation there, but tell us a little bit about the barriers that uh that families are facing when it comes to these diagnosis.</p>
</details>

Terry: 是的，我的意思是，我们不应该创造疗法。一个家庭不应该筹集450万美元，在动物身上进行毒理学研究，寻找制造商。这不是我们应该做的事情。我们面临的障碍是，因为它们不具备商业可行性，所以公司不会花费10亿美元来制造这样的疗法，没有兴趣。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah, I mean it we're not meant to create therapies. A family is not meant to raise $4.5 million, do toxicology in animals, find a manufacturer. This is not something we should be doing. And that's the barrier that we have is that because they're not commercially viable, um that you know companies are not going to spend a billion dollars to make a therapy like this, there's no interest.</p>
</details>

这就是为什么我不得不辞职，创办一家制药公司。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">And that's why when I had to quit my job and start a pharmaceutical company or</p>
</details>

主持人: 你没有医学背景，对吗？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> no medical background, correct?</p>
</details>

Terry: 完全没有医学背景。嗯，我身边有聪明人。所以，你知道，这是一项团队努力。不仅仅是我一个人。有数百人，现在我有一个比我聪明得多的团队，他们负责将这些项目推进到临床，证明它们有效，然后推动它们获得批准。因为现实是，如果我们只治疗一个孩子，那我们对这个社群就做了一件坏事，因为每天都会有孩子出生。在未来20年里，会有成千上万的孩子，他们本可以接受这种疗法，但除非我们获得批准，否则他们将无法得到治疗。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> No medical background at all. Um well, I had smart people around me. So, you know, it was a team effort. It wasn't just me. was hundreds of individuals and now I have a team of people that are much smarter than I am um to get these programs to the clinic, show that they work and then move them towards approval because the reality is if we treat a children, we've really done a disservice for the community because there'll be children born every day. There'll be hundreds of over the next 20 years there'll be thousands of children and they could have been treated with this therapy and they will not have unless we got it approved.</p>
</details>

主持人: 你能帮我们理解这些疾病有多罕见吗？比如迈克尔的病症，全世界有多少人患有它？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Can you help us understand how rare these diseases are? like Michael's condition, how many people in the world have it?</p>
</details>

Terry: 迈克尔是全世界130名患者中的一员。他是加拿大唯一一个患有这种病的孩子。如果从宏观角度看，有1万种罕见病。其中5%有某种疗法，全世界有4亿人患有罕见病。我们中每10个人中就有一个会受到影响。所以，你爱的人，你知道，会患上罕见病。帕金森病、ALS（肌萎缩侧索硬化症）、阿尔茨海默病、贫血、血友病，你认识的人患有或将患有罕见病。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So, Michael, Michael's one of 130 in the world. He's the only child in Canada. Um, if you look, put in perspective, there's 10,000 rare diseases. 5% of them have a therapy of any sort and 400 million people in the world have a rare disease. One in 10 of us will be affected. So, someone that you love, you know, will have a rare disease. Parkinson's, ALS, um Alzheimer's, anemia, hemophilia, someone you know has a rare disease or will have a rare disease.</p>
</details>

主持人: 当你组建家庭时，我想你没有想到这将是你将要进行的斗争，你将成为治疗罕见病的倡导者。为了在这场斗争中取得成功，还需要哪些其他改变？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> When you were starting your family, you I imagine you didn't think that this was what the fight that you were going to be fighting, that you were going to be an advocate for treating rare diseases. What other changes are needed uh to be successful in this fight?</p>
</details>

Terry: 从个人角度来看，当你身处其中时？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Uh from an individual perspective when you're in this?</p>
</details>

主持人: 是的。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah.</p>
</details>

Terry: 嗯，我以前是个内向的人。现在看不出来了。但一旦你做了100次采访，你知道，之后它会让你崩溃。但是你必须有坚强的意志。你知道，当我们第一次讲述我们的故事时，有人告诉我们放弃迈克尔，说他，你知道，他不配活着，你必须有坚强的骨气。你必须有坚强的意志。你必须有永不放弃的态度，你必须有一个支持你的社群。幸运的是，我有一个了不起的妻子和了不起的孩子支持我们。一个了不起的社群站出来说：“我们不会让迈克尔患上这种疾病。我们会支持你。”然后我们很幸运地在旅途中遇到了很多了不起的人，帮助我们做我们需要做的事情才能达到目标。再说一遍，这不是为家庭设计的。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Uh well, I was an introvert. It doesn't show it anymore. But once you do a 100 interviews, you know, it kind of breaks you afterwards. Um, but you have to have a strong will. Um, you know, we were when we first put out our story, people were telling us to put down Michael that he's, you know, that he doesn't deserve to live and you have to have a strong backbone. You have to have a strong will. Um, you have to have a never give up attitude and you have to have a a support community around you. And luckily, I have an amazing wife and amazing children that supported us. um an amazing community that came on and said, "We are not going to let Michael's um have this disorder. We're going to be here for you." And then we were fortunate enough to meet amazing people along the journey to help us do what we needed to do to get there. It was again, it's not meant for families to do this.</p>
</details>

主持人: 我想你肯定会收到来自与你处境相似的家庭的电子邮件、电话和信息。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> I I have to imagine that you get emails, phone calls, messages from families who were in a similar situation uh than you were.</p>
</details>

Terry: 我每周接到15个电话。我来这里路上就接了两个。这是不停的，因为家庭正在努力拯救他们的孩子。他们看到我的故事，想做我做过的事情，其中一些人成功了，一些人没有。我们必须找出办法。我们必须找到前进的道路。值得庆幸的是，技术正在迅速发展。十年前我们认为无法治愈的疾病，现在可以治愈了。如果我们的孩子在五年后出生，那将是另一个故事。我们可能会立即获得治疗。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> I get 15 calls a week. I had two just on the way here. Um it's non-stop because families are trying to save their children. They see my story and they want to do what I did and some of them are successful, some of them are not. Um, and it's something that we have to figure out. We have to figure out a path forward. Thankfully, technology is changing rapidly. Uh, what we thought was non-curable 10 years ago is curable now. And if our children were born 5 years from now, it'd be a different story. We'd have probably therapies right off the bat.</p>
</details>

我们需要做的一些事情是新生儿筛查。我们需要对每个出生的孩子进行基因筛查。这样，当药物进入临床时，我们就可以治疗五个月大、两周大、一个月大的孩子。这些孩子将更接近治愈，而不是仅仅是治疗。因为你可以想象，这就像一个滑动标尺。如果我们足够早地发现他们，

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">Some things we need to do are uh newborn screening. We need to have genetic screening for every single child that's born. That way when a drug is in the clinic, we can treat a five-month-old, a two-week old, a one one month old. And those children will be more towards a cure than a treatment. Because as you can imagine, it's like a sliding scale. If we catch them early enough,</p>
</details>

主持人: 它将更接近治愈。如果我们17岁才治疗他们，治愈的可能性就越来越小，甚至治疗的效果也越来越差，对吗？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> it'll be more towards a cure. If we treat them at 17, it's less and less of a cure, more and less and less of a treatment even, right?</p>
</details>

Terry: 所以这就是我们必须真正加紧努力的地方，政府必须开始真正投资这些新技术和新创新。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So that's where we have to really step up and government has to start really investing in this um new technologies and new innovations.</p>
</details>

### 基因医学的未来展望

主持人: 瑞秋，特里提到了前进的道路。所以我想知道，亨廷顿病的经验如何应用于我们普遍治疗遗传病的方式？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Rachel, Terry had mentioned a path forward. So I am curious how can the the lessons learned in the Huntington's case apply to the way we treat genetic diseases in general.</p>
</details>

Rachel: 是的。我认为，特里所说的任何工作，比如这项工作，都是非常艰难和困难的。我们需要社群动员科学家和政府，让我们找到新的途径，将科学家在实验室中的想法转化为我们可以在临床中测试和开发的东西，而其中最重要的部分是将药物送到患者手中。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah. Well, I think doing any of exactly the work that Terry discusses like this is hard and it's quite difficult. Uh we need a community to mobilize both scientists and government to allow us to find new paths for how can we get drugs from [clears throat] ideas that scientists have in the lab to things that we can test and develop in the clinic to into the most important part of this is getting the drugs to the patients.</p>
</details>

我们特别能预见到的基因疗法最大的障碍之一是，如何实际运行临床试验、如何获得批准，以及最终这些药物有多昂贵。通常，我们谈论的是每位患者100万到500万美元的费用。加拿大卫生部（Health Canada）和其他审批机构将如何监督和管理这些费用，并确保人们能够实际获得可能已经可用的药物治疗，但这些药物却如此昂贵。所以这将是我们必须解决的一个问题。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">And one of the biggest barriers that we can kind of foresee with gene therapies in particular is the barriers for how you actually run the clinical trials, how you actually get approval, and then how expensive those drugs are at the end. Typically, we're talking in the order of maybe$1 to5 million per patient. Um, and how Health Canada and other approval agencies are going to oversee administer that and ensure that people can actually be treated with drugs that are maybe already available. um but they're just so expensive. So that's going to be a problem we've got to figure out.</p>
</details>

主持人: 接下来可能会有哪些疾病受益？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> What kind of diseases uh might be in line? Uh next.</p>
</details>

Rachel: 是个很好的问题。我认为特里提到这个统计数据非常好，即全世界每10个人中就有一个患有罕见病。所以这些都是各种不同的疾病。其中一些我们真的不了解。我们不确定它们是否有遗传基础，或者是否是其他环境因素或其他完全不同的原因。但我想，至少那些有明确遗传基础的疾病，我们有一个非常明确的前进方向，可以利用这些新兴技术，如基因沉默或CRISPR，以及其他类型的编辑技术，来尝试找到可行的疗法。我认为未来5到10年，这方面会非常令人兴奋。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Yeah, it's a great question. I think um I really like that Terry brought up this statistic that one in 10 people in the world have a rare disease. And so these are all kinds of different things. Some of them we really don't understand. We don't really know if they have a genetic basis or if it's some other environmental factors or something else altogether. Um, but I think at least those with a a defined genetic basis, there's a very obvious path forward for how we can use some of these emerging technologies with gene silencing or crisper, other kinds of editing technologies to try and find viable therapeutics and I think that's where things are looking really exciting in the next 5 to 10 years.</p>
</details>

主持人: 好的，我给你们两位的最后一个问题。特里，我先问你。你对未来5到10年基因医学的唯一希望是什么？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> All right, my last question to both of you. Uh, Terry, I'll start you. What's your one hope for the future of genetic medicine in the next say 5 to 10 years?</p>
</details>

Terry: 我的希望是，技术发展到一定程度，孩子出生后，我们在一天内进行基因筛查，第二天他们就能得到治疗。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> My hope is that um the technologies evolved to a certain point where a child is born, we we do a genetic screen within a day and on day two they're getting treated</p>
</details>

我认为我们离那一天不远了。我认为在未来5到10年内，我们将根除这些疾病。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> and I think we're not far from that. I think in the next 5 or 10 years that will be we'll be eradicating disorders.</p>
</details>

这就是为什么我说迈克尔出生得有点太早了。你知道，如果他再晚5年出生，他就会被治愈。不幸的是，他现在出生了。我们必须尽力而为。但我们的希望是，我们能根除这些疾病，这样我们所爱的人就永远不会遭受这些疾病的折磨。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Um and that's why I say Michael was just born a bit too early. You know, if he was born 5 years from now, um he would have been cured. Unfortunately, he was born now. Um and we have to do what we can. But that's our hope is that that we eradicate these these disorders so that our loved ones will never suffer from these diseases.</p>
</details>

主持人: 瑞秋，你来做最后的总结。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Rachel, you get the last word.</p>
</details>

Rachel: 好的。我认为这些技术真正令人兴奋的一点是，其基础科学在10到15年前甚至不存在。这让我对实验室中正在进行的工作充满希望。比如多伦多大学和世界各地其他地方的科学家正在开发什么，以及他们为未来提供了哪些可能性。我认为我们甚至不知道未来5到10年会有哪些技术进入临床。这真的很令人兴奋。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Okay. I think something that's really exciting with these technologies is the underlying science didn't even exist maybe 10, 15 years ago. And so it makes me so hopeful about what is currently in the lab. Like what scientists at University of Toronto and other places around the world, what they're developing and what possibilities they offer for the future. Um, I don't think we even know what technologies will exist that could enter the clinic in the next 5 to 10 years. And that's really exciting.</p>
</details>

主持人: 非常激动人心的时代。瑞秋，我们今天就到这里。非常感谢你的见解。特里，非常感谢你，祝你的家人一切顺利。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Very exciting times. Rachel, I'm going to we're going to leave it there. Thank you so much for your insights. Terry, thank you so much and wish your family all the best.</p>
</details>

Terry: 非常感谢。非常感谢。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Thank you so much. Really appreciate it.</p>
</details>

主持人: 谢谢。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Thank you.</p>
</details>

### 花生过敏预防的范式转变

花生过敏很常见，而且可能致命。多年来，家长们被告知三岁以下的孩子要避免食用花生。但在2015年，这一切都改变了。研究发现，将花生作为婴儿最早的食物之一，实际上可以降低患食物过敏的风险。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Peanut allergies are common and can be deadly. For years, parents were told to avoid feeding them to their kids under three. But in 2015, that all changed. Research found that introducing peanuts as one of a baby's first foods actually cut the risk of developing food allergies.</p>
</details>

今年10月发表在《**儿科学**》（Pediatrics: 一本医学期刊）杂志上的一项研究称，这一更新的指导方针产生了巨大影响。我采访了麦克马斯特大学（McMaster University）医学系助理教授乔什·科伊格（Josh Koig），了解了这项研究揭示了什么，以及它对食物过敏患者意味着什么。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">A study published in the journal Pediatrics this October says this updated guidance has had a big impact. I asked Josh Koig, assistant professor in the department of medicine at McMaster University about what the research shows and what it means for people who suffer from food allergies.</p>
</details>

主持人: 乔什，很高兴邀请到你。你最近怎么样？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Josh, great to have you. How are you doing? doing very well, thanks. Thanks for having me on.</p>
</details>

Josh: 很好，谢谢。谢谢邀请我。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">doing very well, thanks. Thanks for having me on.</p>
</details>

主持人: 当然。作为一名食物过敏研究员，我们看到儿童花生过敏症急剧下降，这有多大的突破性？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Of course. As someone who researches food allergies, how groundbreaking is it that we are seeing peanut allergies plummeting in children?</p>
</details>

Josh: 嗯，我认为这是一个非常有希望的迹象。如你所知，建议从基本上避免过敏原转变为早期引入和在4到6个月大时早期喂食。这大约发生在2017年，这是第一次推荐。2021年，有了更广泛的指南，你知道，这是基于一项名为**LEAP试验**（Learning Early About Peanut Allergy Trial: 一项里程碑式的研究，发现早期引入花生可以显著降低儿童花生过敏的风险）的大型研究。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Um, I think it's a very promising sign. Uh, as you know, the recommendation shifted to uh from basically avoiding allergens early on in life to early introduction and early feeding at about 4 to 6 months of age. Um, and this happened around 2017, which is the first recommendation. And in 2021, there was a more expansive guideline and you know this is based on a large study called the LEAP trial uh where they found that early introduction had a massive impact on becoming allergic to peanut very particularly.</p>
</details>

他们发现早期引入对特别对花生过敏产生了巨大影响。我想现在大概是我们能够看到这种信号开始显现的时候，即我们确实正在影响这种疾病的发病率。嗯，你知道，我不会说数据是，你知道，如你所知，LEAP试验中致敏率下降了81%。我们还没有看到这样的情况。但困难在于，你知道，那是一个非常受控的环境。而在现实世界中，当你在诊所里，全国各地都有诊所，在美国，这项研究就是在这里完成的，你知道，患者的接受度，这些都是仍然悬而未决的问题。但这是一个非常积极的迹象，我认为这是现代历史上我们第一次看到花生过敏率下降。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">And I guess now is probably just around the time that we would be able to see the beginnings of that signal that you know we really are impacting the incidence of this uh of the disease. Um, and you know, I won't say that the the data are um, you know, as you know, there's like an 81% decrease in sensitization in a leap trial. That's not what we're seeing yet. But the difficulty is, you know, that's a very controlled environment. And in the real world when, you know, you're in clinics and there's clinics all across the country in the US, which is where this research was done, uh, you know, uptake by patients, these are all questions that are are, uh, you know, still open. But it's a really positive sign that we are for the first time I think in modern history seeing a decrease in the rate of peanut allergy.</p>
</details>

### 早期引入：科学原理与效果

主持人: 用通俗易懂的话来说，你能帮我们解释一下这里的科学原理吗？为什么引入花生和花生制品，比如花生酱，会导致过敏症的下降？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> In layman terms, can you help us break down the science here? Why does introducing peanuts and peanut products uh like peanut butter um lead to a drop in in allergies?</p>
</details>

Josh: 所以对于我们98%到99%的人来说，花生不是问题。只有在少数1%到2%的人群中，人们才会对花生过敏。当我们吃一种食物时，通常会发生的情况是，我们对它产生所谓的耐受性。我们的免疫系统与肠道协同工作，告诉我们，这些食物没问题。我们需要摄入这些东西以获取营养。所以我们不想有不良反应。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So for you know 98 to 99% of us peanut isn't a problem. Um it's only in a a much smaller fraction 1 to 2% where people become allergic. What typically happens when we eat a food is we become what we call tolerant to it. Our immune system works in tandem with our intestine to say, you know, those foods are okay. We need to take those things in to get nutrients from them. So, we don't want to have a bad reaction.</p>
</details>

但在1%到2%的人群中，这种情况不会发生。相反，他们会对过敏原产生免疫反应。然后，当他们再次接触过敏原时，这种免疫反应就会产生过敏反应的效果。所以我们认为正在发生的是，通过在4到6个月大的时候早期提供过敏原，你以一种受控的方式、在受控的环境中引入过敏原，这样免疫系统就没有时间意外地以负面方式接触过敏原，从而导致过敏。所以本质上，我们只是利用了我们对免疫系统工作原理的了解，并在人们有机会过敏之前，利用这一点使他们产生耐受性。

<details>
<summary>View/Hide Original Original English</summary>
<p class="english-text">But in 1 to 2% of people, uh that doesn't happen. Instead, they mount an immune response against the allergen. And then that immune response can have, you know, the effects of an allergic reaction uh when they see the allergen again. So what we think is going on is that by providing the allergen early on at that 4 to 6 month time point you're introducing allergen in a controlled way in a controlled environment such that the immune system hasn't had time to accidentally be exposed to the allergen in a negative way that would make you allergic. So essentially we're just taking advantage of what we know about how the immune system works and and using that to tolerize people before they have the opportunity to become allergic.</p>
</details>

我可以想象有些人正在看这项研究，并且非常兴奋。他们可能对花生制品不过敏，但他们可能对其他东西过敏，我很好奇，是否建议我们尝试其他过敏原，比如坚果或鸡蛋。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">I can imagine there are people who are looking at this study and are quite excited. They may not be um allergic to peanut products but they might be allergic to something else and I am curious is it recommended that uh we try other allergens like uh tree nuts or eggs.</p>
</details>

Josh: 我不是临床医生，所以我不能提供临床建议，但我可以说，你知道，在与我的临床同事交谈时，实际上有一些早期引入所有食物的推荐时间表，因为他们认为这确实是我们降低新花生过敏发病率的方法。但正如这项研究清楚表明的那样，你知道，我们没有看到这些患者中出现81%的下降。下降幅度远小于此。而且人们仍然会过敏。所以，你知道，我认为，是的，遵循这些时间表是非常重要的一部分，但另一个重要的事情是，人们仍然过敏，并且正在过敏，我们确实需要找到处理这些人的方法。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">So I'm not a clinician so I can't provide clinical recommendations but I can say that uh you know in speaking with my clinical colleagues there are actually schedules that are recommended for early introduction of essentially all foods because they think that that really is the way that we are going to you know decrease the incidence of new peanut allergies. But as clearly evident by this study you know it wasn't an 81% decrease that we saw you know in these patients. It was it was much less than that. Um and people are still becoming allergic. So, you know, I think that yeah, you know, following those schedules is a really important piece of this, but another important thing is that people are still allergic and are becoming allergic and we do need to find ways to deal with those people as well.</p>
</details>

主持人: 所以，我想澄清一下。即使人们在很小的时候就接触过花生制品或其他产品，他们仍然可能对它们过敏吗？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So, I want to clarify. So, people can still be allergic to peanut products or other products even if they've had them at at a young age.</p>
</details>

Josh: 嗯，你问了一个很好的问题。我想我们不完全知道这个问题的答案。通常会发生的情况是，人们在第一次接触食物时，他们的孩子立即产生反应，然后他们不得不去医院，然后被诊断出来。所以本质上，那里的思考过程是，他们在早期引入之前就已经过敏了。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> So, um you ask a very good question. I suppose we don't know exactly the answer to that question. What tends to happen is that people on that first introduction to the food, their child have a reaction right away and then they end up having to go to hospital and then they end up being diagnosed. So essentially the thought process there is that they've already become allergic before the early introduction.</p>
</details>

### 对抗医疗错误信息

主持人: 花生过敏症一直备受关注，不仅因为这项研究，你还提到了美国。我实际上想播放一段视频。这是小罗伯特·F·肯尼迪（Robert F. Kennedy Jr.）的片段，我们知道他是美国卫生与公众服务部部长。他最近接受了一次采访，谈到了花生过敏症以及婴儿接触花生制品的问题。让我们听听他说什么。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Peanut allergies has been getting a lot of headlines not only uh from this study uh and you had mentioned the US. I actually want to to uh pull a clip. Uh this is from Robert F. Kennedy Jr. who is as we know the US Secretary of Health and Human Services. He gave an interview recently uh talking about peanut allergies and exposing infants uh to peanut products. Let's have a listen to that.</p>
</details>

小罗伯特·F·肯尼迪: 对我来说，这并不是一个令人信服的假设，因为首先，根据我个人的经验，我的家里到处都是花生酱，我每天吃两顿花生酱，我的妻子怀孕时也吃花生酱，孩子们一能咀嚼食物就给他们吃花生酱，但我们家里仍然有人花生过敏。我们需要看看疫苗中的铝佐剂，这与时间线完美吻合。铝的增加与过敏症的扩大同步，这始于1989年。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">To me that is not a convincing hypothesis because number one in my own personal uh experience was my house was was so filled with peanut butter and I was eating peanut butter two meals a day and my wife when she was pregnant was eating peanut butter and the kids were given peanut butter from as soon as they could chew food and yet we still had peanut allergies in our house. We need to look at um aluminum adgivants and vaccines um which fit the timeline perfectly. The increase of aluminum and the is is in lock step which began in 1989 which is in lock step with the expansion of allergies.</p>
</details>

主持人: 作为一名研究员，我必须问，听完这段视频，你的回应是什么？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> As a researcher I have to ask what is your response uh listening to that video?</p>
</details>

Josh: 嗯，你知道，一方面，这是轶事。嗯，你知道，肯尼迪先生的孩子们患有花生过敏症，这真的很不幸。但你知道，这项研究涉及数万人。所以，这是一个比轶事研究大得多的总体数据。嗯，你知道，没有任何证据支持疫苗中的铝与过敏症有关的说法。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">Um well, you know, on the one hand, anecdotal, um you know, it's really unfortunate that uh uh Mr. Kennedy's uh children have peanut allergies. Um but, you know, this study involved tens of thousands of people. So, this is an agg, you know, much larger aggregate than than an anecdotal study. um you know there really isn't any evidence that would support the notion that alum or aluminium in uh uh vaccines is associated with allergy at all.</p>
</details>

事实上，你知道，已经有多项我们称之为**系统性综述**（Systematic Reviews: 一种研究方法，通过对现有多个研究进行全面、系统地评估和综合，以回答特定的研究问题）的研究，它们本质上是审视了许多不同的研究，试图探究这一点，结果基本上没有发现疫苗接种与过敏之间存在任何关联。嗯，而且，我想我对他的时间线有点异议，因为我很确定铝最早是在1930年代左右引入的，并且在疫苗中使用了70多年了。而他所说的流行率增长通常是从1990年代开始的。所以，我不太相信这是一种解释。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">In fact, you know, there's been multiple what we call systematic reviews which essentially looking at many different studies that have tried to look at this and essentially there's no connection between vaccination and becoming allergic as far as we can see. Um, and uh, I suppose I have a small issue with the timeline there because I'm pretty sure that alum was first introduced in like the 1930s and has been in vaccines for the better part of 70 years or something like that. And, you know, the prevalence increases that he's talking about generally are from the 1990s onward. So, I I'm I'm not really I I I'm not sure I buy that as a as an explanation.</p>
</details>

你知道，我们真的不知道为什么过敏症的流行率一直在上升。我认为这是一个主要问题，而且，你知道，我认为，与肯尼迪先生所说的相反，我认为有许多杰出的研究人员正在努力解决这个问题。他们正在努力找出导致这些过敏性疾病增加的原因，你知道，目前还没有达成共识，但我真的没有看到任何证据表明这与疫苗接种有关。事实上，恰恰相反。我会说研究表明，例如，如果你接种疫苗，你患湿疹的可能性会更小。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">You know, we really don't know why the prevalence of allergy has been on the rise. Um and I think that that's a major issue and and you know I don't think I you know in contrast to what Dr. sorry Mr. Kennedy is saying there I think um you know there are many fantastic researchers that are trying to figure this out. They're trying to figure out what was been causing the increase in these allergic diseases and you know really consensus hasn't come about on that but I really I don't see any evidence that it would be anything related to vaccination. In fact, the opposite. I would say studies are kind of suggesting that, you know, for example, if you get a vaccine, you're less likely to have eczema.</p>
</details>

主持人: 好的，我想就正在进行的研究这一点继续讨论。我们是否更接近于确定食物过敏的原因？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Well, I want to pick up on that in terms of the research that's being done. Are we any closer to identifying the what, like what causes food allergies?</p>
</details>

Josh: 嗯，你知道，不幸的是，并没有真正接近。嗯，你知道，再说一遍，这不是因为我们没有努力。困难在于人们在很小的时候就过敏了。所以，想想我们如何才能知道这些信息。大多数时候，我们知道某人过敏是因为他们吃了过敏原，产生了不良反应并去了医院。所以试图弄清楚在那之前发生了什么很困难，因为我们不知道，你知道，一百人中可能只有一两个人会对花生过敏，而且我们很难确定这些原因。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Uh, well, you know, unfortunately, not really. Um, you know, again, not for a lack of trying. The difficulty with this is people become allergic, very very early. So, think about how we could know this piece of information. Most times we know that someone's allergic when they've eaten an allergen, had a bad reaction and gone to hospital. So trying to figure out what happened before that is difficult because we don't know of the you know out of a hundred people maybe one or two might become allergic to peanut right um and it's been very difficult for us to pin those down.</p>
</details>

我们发现的一些与此相关的因素，例如婴儿油中的花生油，这些东西导致了改变，所以你现在不会在婴儿油中找到花生油了，因为存在致敏的可能性，研究人员发现了这一点，我们因此实施了改变以避免潜在的问题。所以，我认为这些大型**流行病学研究**（Epidemiological Studies: 研究疾病在人群中的分布、决定因素和控制方法）很可能在未来揭示新的事物。但就目前而言，我认为更大的问题是如何进行预防，以及当人们过敏时，我们如何让他们基本上不再过敏，并让他们有机会过上正常的生活。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">and the things that we have found that have made some associations for example like peanut oils in baby oil uh those things resulted in changes so you won't find peanut oil in baby oil anymore because of the possibility that you might be sensitized and researchers found that out and we enacted changes to you know avoid that potential issue so um I think these large epidemiological studies are likely to reveal new things in the future. But for right now, I I think the bigger issue is how can we engage in prevention and then how can we engage when people are allergic to basically stop them from being allergic and give them the opportunity to live a regular life.</p>
</details>

### 花生过敏疫苗与信息战

主持人: 好的，我想稍微换个话题。我想谈谈我们正处于一个充斥着虚假信息和错误信息的时代，尤其是在谈论医疗保健时。我想谈谈一个Facebook帖子，它声称有一种花生过敏疫苗。我不得不想象，你和你的同事们，那些深入研究过敏症的人，可能是第一批知道这项工作正在进行的人。所以，当然，情况并非如此。你和你的几位麦克马斯特大学的同事发表了一份声明，称这不是真的。但人们很好奇。花生过敏疫苗正在研发中吗？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> All right, I want to change gears a little bit. I want to talk about we're in an age of of disinformation and misinformation particularly when we talk about uh healthcare. Um, and I want to talk about a a Facebook post uh that claimed there was a vaccine for peanut allergies. And I have to imagine that you and your colleagues who are deep in this research in allergies would probably be one of the first people to know that this was in the works. And so, uh, this was not the case. Of course, you and several of your colleagues at McMaster put out a statement to say it wasn't true. But people are are curious. Is there a vaccine in the works for peanut allergies?</p>
</details>

Josh: 嗯，是的，我的意思是，我认为那是一个不幸的情况，是人工智能（AI）在一些潜在真实信息的基础上**AI幻觉**（AI Hallucinating: 人工智能生成虚假或不准确信息，但听起来合理的情况），然后又加上了许多胡言乱语。嗯，你知道，我们正在进行多项研究，测试食物过敏的潜在疗法，并试图找出有哪些可用的选择以及哪些会有效。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">Um, so yeah, I mean I think that that was an unfortunate situation of AI hallucinating uh based on on some potentially truthful information and then uh a lot of essentially gibberish. Um, you know, we are uh engaged in in multiple studies testing potential therapeutics uh in food allergy and you know trying to figure out what what options are available and what's going to be effective.</p>
</details>

你知道，在早期开发阶段。我们确实有一些研究正在探索本质上是疫苗的东西。但是，你知道，它们离我们将其用于人类并看到对人类产生影响的程度还差得很远。而且，你知道，这非常不幸，因为我绝对希望能够对这里的所有人说，你知道，我有解决方案。嗯，我没有，但我可以告诉你，我睡得很少，因为我正在努力解决这个问题，我一直在努力，我的所有同事也是如此。所以我们正在为此非常努力地工作，而且，你知道，我们有多种调查途径来尝试做到这一点，同时也在努力找出，你知道，过敏的原因是什么，是什么让过敏在人们身上持续存在，我们希望通过这些研究项目，我们能够找到有效的干预措施，对人们产生影响。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">you know, early in development. We do have some, uh, studies looking at what would essentially be vaccines. Um, but, you know, they're nowhere near the point where we're giving them to humans and seeing an impact in the human. And, you know, it's very unfortunate because I I would absolutely love to say to everyone here, you know, I have the solution. Um, I don't, but I can tell you I don't sleep very much because I'm on the case and I'm always trying. I'm always working towards it and so are all of my colleagues. So we're we're working really hard towards this and uh you know we have multiple lines of inquiry to try and do this as well as trying to figure out you know what causes allergy, what makes allergy persistent in people and we're hoping through those research programs we'll be able to find good interventions that will have an impact on people.</p>
</details>

主持人: 好的，让我们就对抗错误信息和虚假信息这一点继续讨论，作为一名研究员。这场战斗怎么样？你做了什么？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Well let's stick on that point about sort of battling the misinformation disinformation as as a researcher. Uh how is that battle? What do you do?</p>
</details>

Josh: 这是一个非常棒的问题，你知道，我认为像这样的参与是很好的机会。我，你知道，我确实知道我的同事和我都被我们必须做的工作量所淹没，无论是在研究项目内部还是之外。所以，你知道，进行参与的概念是，我们做得不如我们想的那么多。所以我认为我们需要做的一件事是更多地与社群互动，你知道，当我与社群成员互动时，我们通过**加拿大食物过敏协会**（Food Allergy Canada: 一个致力于支持食物过敏患者和研究的组织）做了很多，这是一个合作伙伴组织，一个很棒的合作伙伴组织，嗯，你知道，我发现人们往往会说：“哦，好吧，现在这个人有了名字。”

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">It's a really fantastic question and you know I think engagements like these are are good opportunities. I you know I definitely know that my colleagues and I were you know overwhelmed by the amount of work that we have to do both within the research program and then beyond. So you know the notion of uh doing engagement is is is we don't do it as much as we would like to. So I think one piece that we need to do is engage more with the community and and you know when I engage with community members which we do quite a bit through Food Allergy Canada which is a partner organization a fantastic partner organization um you know I I find that people tend to go oh okay well now here's a face to a name.</p>
</details>

但困难在于虚假信息传播的速度太快了，我们很难，你知道，切断所有出现的信息，并对所有事情发表声明，当这些声明，你知道，非常明显是假的，并且非常明显是关于我们的时候。在这种虚假信息宣传或这种虚假信息AI帖子的情况下，情况会稍微容易一些，但，你知道，我认为这是一个开放的问题。作为研究人员，我们如何展示我们正在做的工作，以试图影响这个问题，并，你知道，重新获得普通社群的信任？

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">but the difficulty is that the disinformation process is so fast and it's really hard for us to you know cut off everything that comes out and and you know make statements about everything when the statements are you know very clearly false and very clearly about us. It's a little easier like in this disinformation campaign uh or this disinformation AI post situation, but um you know I I think that this is an open question. How do we as researchers demonstrate what we're doing to try and impact this problem and and you know get the trust of the general community back?</p>
</details>

主持人: 乔什，非常感谢。非常感谢你的见解和研究。这真是令人兴奋的事情。非常感谢你。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Josh, really appreciate. Thank you so much for your insights and your research. This is really exciting stuff. Thank you so much.</p>
</details>

Josh: 非常感谢邀请我。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">>> Thanks so much for having me. [music]</p>
</details>

今天是“捐赠星期二”，我们请求您帮助我们支持媒体素养，并让安大略省居民了解情况。请在今晚午夜前在tvo.org/givingTuesday捐款，每笔捐款都将获得最高25万美元的配捐。捐赠100美元或更多，您将获得自己的限量版复古TBO毛线帽。您的支持将建设一个更强大、信息更灵通的安大略。在此之前，我们明天再见。

<details>
<summary>View/Hide Original English</summary>
<p class="english-text">Today is Giving Tuesday and we're asking you to help us support media literacy and keeping Ontarians informed. Donate before midnight tonight at tvo.org/giving Tuesday and every gift will be matched up to $250,000. Donate $100 or more and you'll get your very own limited edition retro TBO toque. Your support builds a stronger, more informed Ontario. Until then, we'll see you tomorrow.</p>
</details>